Dyee Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Venture Capital, Private Equity
Stage Focus
Early Stage, Late Stage
Geographical Focus
United States, China
Industries Focus
- Financial Services
- Real Estate
- Consumer & Retail
- Logistics
- Health Care
- Food and Beverage
- Biotechnology
- Pharmaceutical
- Therapeutics
- Medical
- Biopharma
- Medical Device
- Snack Food
- Energy & Industrial Tech
Investment Size:
10,000,000 to 50,000,000 USD
Investor Details Founded: 2016
Dyee Capital is an investment firm specializing in early and late-stage venture capital and private equity investments. The firm focuses on sectors such as biotechnology, pharmaceuticals, medical devices, biopharmaceuticals, health care, medical therapeutics, food and beverage, snack food, logistics, consumer and retail, energy and industrial technology, real estate, and financial services. Dyee Capital operates in China and the United States, with a particular emphasis on the Chinese market.
The firm's investment strategy involves participating in funding rounds with multiple investors, typically ranging from 10 to 50 million USD. Dyee Capital has a history of leading investments and has been involved in several significant funding rounds, including investments in companies like BridGene Biosciences, Degron Therapeutics, and InventisBio. The firm has a track record of supporting companies in various stages of development, from early-stage ventures to late-stage growth.
Dyee Capital is headquartered in Xiamen, Fujian, China. The firm's contact information includes an email address at info@dyeecapital.com and a phone number at +86 0592-2518818. For more information, visit their official website at https://www.dyeecapital.com/.
Requirements
- Companies in biotechnology, pharmaceuticals, medical devices, biopharmaceuticals, health care, medical therapeutics, food and beverage, snack food, logistics, consumer and retail, energy and industrial technology, real estate, and financial services sectors.
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- BridGene Biosciences
- Degron Therapeutics
- InventisBio
Mentioned In
-
$24.95
-
$14.95
-
$19.95
-
$9.95
-
$99.00
-
$9.95
-
$99.00
Claim this Investor
Are you an official representative of Dyee Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim